Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

A rare pulmonary pathology complicated with an unusual condition.

Kotoulas SC, Manika K, Pilianidis G, Tsikouriadis P, Kalopitas G, Petridis N, Apsemidou A, Iakovos A, Kioumis I.

Breathe (Sheff). 2019 Jun;15(2):121-127. doi: 10.1183/20734735.0117-2019.

2.

Limited Sampling Strategies Using Linear Regression and the Bayesian Approach for Therapeutic Drug Monitoring of Moxifloxacin in Tuberculosis Patients.

van den Elsen SHJ, Sturkenboom MGG, Akkerman OW, Manika K, Kioumis IP, van der Werf TS, Johnson JL, Peloquin C, Touw DJ, Alffenaar JC.

Antimicrob Agents Chemother. 2019 Jun 24;63(7). pii: e00384-19. doi: 10.1128/AAC.00384-19. Print 2019 Jul.

PMID:
31010868
3.

Burden and Characteristics of the Comorbidity Tuberculosis-Diabetes in Europe: TBnet Prevalence Survey and Case-Control Study.

Sane Schepisi M, Navarra A, Altet Gomez MN, Dudnyk A, Dyrhol-Riise AM, Esteban J, Giorgetti PF, Gualano G, Guglielmetti L, Heyckendorf J, Kaluzhenina A, Lange B, Lange C, Manika K, Miah J, Nanovic Z, Pontali E, Prego MR, Solovic I, Tiberi S, Palmieri F, Girardi E.

Open Forum Infect Dis. 2018 Dec 19;6(1):ofy337. doi: 10.1093/ofid/ofy337. eCollection 2019 Jan.

4.

Moxifloxacin in Chronic Obstructive Pulmonary Disease: Pharmacokinetics and Penetration into Bronchial Secretions in Ward and Intensive Care Unit Patients.

Sionidou M, Manika K, Pitsiou G, Kontou P, Chatzika K, Zarogoulidis P, Kioumis I.

Antimicrob Agents Chemother. 2019 Feb 26;63(3). pii: e01974-18. doi: 10.1128/AAC.01974-18. Print 2019 Mar.

5.

Genetic diversity of mycobacterium tuberculosis in northern Greece.

Kazdaglis G, Molina-Moya B, Manika K, Ioannidis P, Papaventsis D, Vogiatzakis E, Panopoulou M, Melidou A, Domínguez J, Malisiovas N, Gioula G.

J Biol Regul Homeost Agents. 2018 Jul-Aug;32(4):931-936.

PMID:
30043579
6.

Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study.

Borisov SE, Dheda K, Enwerem M, Romero Leyet R, D'Ambrosio L, Centis R, Sotgiu G, Tiberi S, Alffenaar JW, Maryandyshev A, Belilovski E, Ganatra S, Skrahina A, Akkerman O, Aleksa A, Amale R, Artsukevich J, Bruchfeld J, Caminero JA, Carpena Martinez I, Codecasa L, Dalcolmo M, Denholm J, Douglas P, Duarte R, Esmail A, Fadul M, Filippov A, Davies Forsman L, Gaga M, Garcia-Fuertes JA, García-García JM, Gualano G, Jonsson J, Kunst H, Lau JS, Lazaro Mastrapa B, Teran Troya JL, Manga S, Manika K, González Montaner P, Mullerpattan J, Oelofse S, Ortelli M, Palmero DJ, Palmieri F, Papalia A, Papavasileiou A, Payen MC, Pontali E, Robalo Cordeiro C, Saderi L, Sadutshang TD, Sanukevich T, Solodovnikova V, Spanevello A, Topgyal S, Toscanini F, Tramontana AR, Udwadia ZF, Viggiani P, White V, Zumla A, Migliori GB.

Eur Respir J. 2017 May 21;49(5). pii: 1700387. doi: 10.1183/13993003.00387-2017. Print 2017 May.

7.

Miliary tuberculosis in a patient with tuberculous mycotic aneurysm of the abdominal aorta: Case report and review of the literature.

Manika K, Efthymiou C, Damianidis G, Zioga E, Papadaki E, Lagoudi K, Kioumis I.

Respir Med Case Rep. 2017 Mar 20;21:30-35. doi: 10.1016/j.rmcr.2017.03.010. eCollection 2017.

8.

Immunomodulatory effect of macrolides: At what cost?

Kipourou M, Manika K, Papavasileiou A, Pitsiou G, Lada M, Ntinapogias E, Kioumis I.

Respir Med Case Rep. 2016 Jan 15;17:44-6. doi: 10.1016/j.rmcr.2016.01.004. eCollection 2016.

9.

Rifampicin-moxifloxacin interaction in tuberculosis treatment: a real-life study.

Manika K, Chatzika K, Papaioannou M, Kontou P, Boutou A, Zarogoulidis K, Kioumis I.

Int J Tuberc Lung Dis. 2015 Nov;19(11):1383-7. doi: 10.5588/ijtld.14.0935.

PMID:
26467592
10.

Distribution of nontuberculous mycobacteria in treated patients with pulmonary disease in Greece - relation to microbiological data.

Manika K, Tsikrika S, Tsaroucha E, Karabela S, Karachaliou I, Bosmi I, Kioumis I, Papavasileiou A.

Future Microbiol. 2015;10(8):1301-6. doi: 10.2217/FMB.15.50. Epub 2015 Jul 30.

PMID:
26226382
11.

Pneumothorax in sarcoidosis.

Manika K, Kioumis I, Zarogoulidis K, Kougioumtzi I, Dryllis G, Pitsiou G, Machairiotis N, Katsikogiannis N, Lampaki S, Papaiwannou A, Zaric B, Branislav P, Huang H, Li Q, Steiropoulos P, Zarogoulidis P.

J Thorac Dis. 2014 Oct;6(Suppl 4):S466-9. doi: 10.3978/j.issn.2072-1439.2014.09.11. Review.

12.

Chronic thromboembolic pulmonary hypertension: do not miss the chance for an early diagnosis.

Bagalas V, Paspala A, Sourla E, Akritidou S, Tsolakidou K, Boutou A, Pitsis AA, Manika K, Kioumis IP, Stanopoulos I, Pitsiou G.

Am J Case Rep. 2014 Sep 5;15:378-81. doi: 10.12659/AJCR.891014.

13.

Bronchoalveolar lavage fluid and blood natural killer and natural killer T-like cells in cryptogenic organizing pneumonia.

Papakosta D, Manika K, Gounari E, Kyriazis G, Kontakiotis T, Spyropoulos G, Kontakioti E, Zarogoulidis K.

Respirology. 2014 Jul;19(5):748-54. doi: 10.1111/resp.12305. Epub 2014 May 29.

14.

COPD assessment test: a simple tool to evaluate disease severity and response to treatment.

Papaioannou M, Pitsiou G, Manika K, Kontou P, Zarogoulidis P, Sichletidis L, Kioumis IP.

COPD. 2014 Sep;11(5):489-95. doi: 10.3109/15412555.2014.898034. Epub 2014 Apr 25.

PMID:
24766370
15.

Experimentation with inhaled bronchodilators and corticosteroids.

Zarogoulidis P, Porpodis K, Kioumis I, Petridis D, Lampaki S, Spyratos D, Papaiwannou A, Organtzis J, Kontakiotis T, Manika K, Darwiche K, Freitag L, Tsiouda T, Papakosta D, Zarogoulidis K.

Int J Pharm. 2014 Jan 30;461(1-2):411-8. doi: 10.1016/j.ijpharm.2013.12.010. Epub 2013 Dec 17.

PMID:
24361267
16.

Moxifloxacin pharmacokinetics and pleural fluid penetration in patients with pleural effusion.

Chatzika K, Manika K, Kontou P, Pitsiou G, Papakosta D, Zarogoulidis K, Kioumis I.

Antimicrob Agents Chemother. 2014;58(3):1315-9. doi: 10.1128/AAC.02291-13. Epub 2013 Dec 9.

17.

Rifampicin-associated acute renal failure and hemolysis: a rather uncommon but severe complication.

Manika K, Tasiopoulou K, Vlogiaris L, Lada M, Papaemmanouil S, Zarogoulidis K, Kioumis I.

Ren Fail. 2013 Sep;35(8):1179-81. doi: 10.3109/0886022X.2013.815567. Epub 2013 Jul 25.

PMID:
23883374
18.

Pharmacokinetics of moxifloxacin and high-dose levofloxacin in severe lower respiratory tract infections.

Kontou P, Manika K, Chatzika K, Papaioannou M, Sionidou M, Pitsiou G, Kioumis I.

Int J Antimicrob Agents. 2013 Sep;42(3):262-7. doi: 10.1016/j.ijantimicag.2013.04.028. Epub 2013 Jul 4.

PMID:
23830621
19.

In vivo synergistic cytogenetic effects of aminophylline on lymphocyte cultures from patients with lung cancer undergoing chemotherapy.

Mylonaki E, Manika K, Zarogoulidis P, Domvri K, Voutsas V, Zarogoulidis K, Mourelatos D.

Mutat Res. 2012 Dec;740(1-2):1-5. doi: 10.1016/j.mrfmmm.2012.10.002. Epub 2012 Oct 29.

PMID:
23116732
20.

Fibrinous tumor of the pleura: an orphan disease lost in translation.

Zarogoulidis P, Draba V, Machairiotis N, Manika K, Mikroulis D, Tsakiridis K, Courcoutsakis N, Kioumis I, Zissimopoulos A, Zarogoulidis K.

J Thorac Dis. 2012 Oct;4(5):497-503. doi: 10.3978/j.issn.2072-1439.2012.07.09.

21.

Moxifloxacin in multidrug-resistant tuberculosis: is there any indication for therapeutic drug monitoring?

Manika K, Chatzika K, Zarogoulidis K, Kioumis I.

Eur Respir J. 2012 Oct;40(4):1051-3. No abstract available.

22.

The Impact of Pulmonary Arterial Pressure on Exercise Capacity in Mild-to-Moderate Cystic Fibrosis: A Case Control Study.

Manika K, Pitsiou GG, Boutou AK, Tsaoussis V, Chavouzis N, Antoniou M, Fotoulaki M, Stanopoulos I, Kioumis I.

Pulm Med. 2012;2012:252345. doi: 10.1155/2012/252345. Epub 2012 Jul 29.

23.

Multidrug-resistant tuberculosis in an adult with cystic fibrosis.

Manika K, Giouleka P, Zarogoulidis K, Kioumis I.

Respiration. 2013;85(4):350-3. doi: 10.1159/000338846. Epub 2012 Aug 3.

24.

The effect of combination IFN-alpha-2a with usual antituberculosis chemotherapy in non-responding tuberculosis and diabetes mellitus: a case report and review of the literature.

Zarogoulidis P, Kioumis I, Papanas N, Manika K, Kontakiotis T, Papagianis A, Zarogoulidis K.

J Chemother. 2012 Jun;24(3):173-7. doi: 10.1179/1973947812Y.0000000005. Review.

PMID:
22759763
25.

NK cell populations in collagen vascular disease.

Papakosta D, Manika K, Kyriazis G, Kontakiotis T, Zarogoulidis K.

Clin Exp Rheumatol. 2012 Sep-Oct;30(5):693-9. Epub 2012 Oct 17.

PMID:
22704071
26.

Asthma control test is correlated to FEV1 and nitric oxide in Greek asthmatic patients: influence of treatment.

Papakosta D, Latsios D, Manika K, Porpodis K, Kontakioti E, Gioulekas D.

J Asthma. 2011 Nov;48(9):901-6. doi: 10.3109/02770903.2011.611958. Epub 2011 Sep 16.

PMID:
21923284
27.

Pulmonary rehabilitation in non-small cell lung cancer patients after completion of treatment.

Glattki GP, Manika K, Sichletidis L, Alexe G, Brenke R, Spyratos D.

Am J Clin Oncol. 2012 Apr;35(2):120-5. doi: 10.1097/COC.0b013e318209ced7.

PMID:
21378541
28.

Ameloblastoma of the mandible with pulmonary metastases 45 years after initial diagnosis.

Papaioannou M, Manika K, Tsaoussis B, Cheva A, Sichletidis L, Kioumis J.

Respirology. 2009 Nov;14(8):1208-11. doi: 10.1111/j.1440-1843.2009.01613.x. Epub 2009 Sep 1. Review.

PMID:
19732391
29.

Long-term prognosis of asthma is good--a 12-year follow-up study. Influence of treatment.

Porpodis K, Papakosta D, Manika K, Kontakiotis T, Gaga M, Sichletidis L, Gioulekas D.

J Asthma. 2009 Aug;46(6):625-31. doi: 10.1080/02770900903029796.

PMID:
19657907
30.

Bronchoalveolar lavage fluid eosinophils are correlated to natural killer cells in eosinophilic pneumonias.

Papakosta D, Manika K, Kyriazis G, Kontakiotis T, Gioulekas D, Polyzoni T, Bouros D, Patakas D.

Respiration. 2009;78(2):177-84. doi: 10.1159/000203989. Epub 2009 Feb 21.

PMID:
19246876
31.

Efficacy and safety of erythromycin as sclerosing agent in patients with recurrent malignant pleural effusion.

Balassoulis G, Sichletidis L, Spyratos D, Chloros D, Zarogoulidis K, Kontakiotis T, Bagalas V, Porpodis K, Manika K, Patakas D.

Am J Clin Oncol. 2008 Aug;31(4):384-9. doi: 10.1097/COC.0b013e318165c061.

PMID:
18845999
32.

Epstein-Barr virus DNA in bronchoalveolar lavage fluid from patients with idiopathic pulmonary fibrosis.

Manika K, Alexiou-Daniel S, Papakosta D, Papa A, Kontakiotis T, Patakas D, Antoniadis A.

Sarcoidosis Vasc Diffuse Lung Dis. 2007 Sep;24(2):134-40.

PMID:
18496984
33.

Expiratory flow limitation in patients with pleural effusion.

Spyratos D, Sichletidis L, Manika K, Kontakiotis T, Chloros D, Patakas D.

Respiration. 2007;74(5):572-8. Epub 2007 Mar 30.

PMID:
17396027
34.

Prevalence of Rickettsia conorii and Rickettsia typhi infections in the population of northern Greece.

Daniel SA, Manika K, Arvanmdou M, Antoniadis A.

Am J Trop Med Hyg. 2002 Jan;66(1):76-9.

PMID:
12135273
35.

Serologic evidence of human granulocytic ehrlichiosis, Greece.

Daniel SA, Manika K, Arvanitidou M, Diza E, Symeonidis N, Antoniadis A.

Emerg Infect Dis. 2002 Jun;8(6):643-4. No abstract available.

Supplemental Content

Loading ...
Support Center